Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-07 | James Huang ... Executive Chair ... 2020 ... 55 ... Mr. Huang has served as a member of our board since July 2020, our Chair from January 2021 until February 2021, and our Executive Chair since February 2021. ... James Huang ... 278,301 |
| 2022-04-27 | James Huang ... Chair ... Age 56 ... The current members of the committees are as follows: Audit ... James Huang ... X X ... Compensation ... James Huang ... X ... Corporate Governance and Nominating ... James Huang ... X ... Director Compensation Table ... James Huang ... Total ($) 298,097 |
| 2023-04-25 | "James Huang ... Chair ... 57" and "Director Compensation Table ... James Huang ... Total ($) 206,950" |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-30 | Mr. Huang has served as Chairman of the Board since December 2018. Mr. Huang is a founding and Managing Partner to Panacea Venture. Mr. Huang received an M.B.A. from the Stanford Graduate School of Business and a B.S. degree in chemical engineering from the University of California, Berkeley. Non-employee director compensation 2020: James Huang $65,000. |
| 2022-05-11 | Mr. Huang has served as Chairman of the Board since December 2018. Mr. Huang is a Founding Managing Partner of Panacea Venture. Panacea Venture is a venture capital firm that focuses on investments in innovation and transformative early and growth healthcare and life sciences companies worldwide. |
| 2023-01-10 | James Huang Chairman of the Board |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-06